The Rise and Fall of Sarepta Therapeutics’ Gene Therapy for Duchenne Muscular Dystrophy For Rachel DeConti and her son Jacob,…
Browsing: Sarepta
Sarepta Therapeutics, a company facing regulatory scrutiny regarding its gene therapy for Duchenne muscular dystrophy, has reportedly hired a lobbying…
Surprising FDA Reversal Allows Sarepta to Resume Gene Therapy Treatment On Monday afternoon, the FDA made a shocking reversal just…
The heartbreaking news of the FDA’s request for Sarepta Therapeutics to halt shipments of Elevidys, a gene therapy for Duchenne…
This week in InnovationRx focuses on Sarepta’s clash with the FDA, Moderna’s utilization of quantum computers, a new top drug…
Sarepta Therapeutics made a surprising announcement on Monday evening, revealing that it will be pausing all shipments of Elevidys, its…
In the realm of cutting-edge biotech innovation, the recent death of a teenager undergoing Sarepta Therapeutics’ gene therapy Elevidys for…
